Sunday, May 20, 2018
 
 
Company News: Page (1) of 1 - 02/12/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
The Charles E. Holman Morgellons Disease Foundation (CEHMDF) is Kicking Off The Month of February With a Bang
 
(February 12, 2018)
The Charles E. Holman Morgellons Disease Foundation (CEHMDF) is Kicking Off The Month of February With a Bang

For the first time ever, the CEHMDF has officially designated the month of February as Morgellons Awareness Month. February was chosen in celebration of Charles E. Holman, founder of the organization, whose birthday was ?February 12th.

On February 1st, the documentary film, Skin Deep: The Battle Over Morgellons launched their Kickstarter campaign. The foundation president, Cindy Casey, and many other members of the CEHMDF have an active role in this film. Director Pi Ware and his team are committed to raising awareness and creating empathy by sharing the stories of Morgellons patients, the physicians who treat them, and the science behind the disease. “Fortunately," states Pi Ware, the film's director, "we have filmed 80% of our footage already, which means the challenges of finding the characters and story are already behind us. We just need this funding to get us to the editorial finish line.Our goals with Skin Deep are to show the reality of this devastating disease and to inspire both hope and government funding for research." In honor of Morgellons Awareness Month, Skin Deep has released a 3 minute trailer and launched their the Kickstarter campaign at: bit.ly/SkinDeepMovie

In addition, the Facebook page for Skin Deep: The Battle Over Morgellons has created a new Morgellons Awareness Month Facebook frame for profile photos at https://www.facebook.com/morgellonsmovie/posts/957228704427824.



The CEHMDF holds an annual conference in Austin, TX and February 1st marked the opening day of early bird registration for the 11th Annual Medical-Scientific Conference on Morgellons to be held ?on April 14-15, 2018 at the Wyndham Garden Hotel in Austin. This conference brings physicians, scientists, nurses, patients and their families together for 2 days of presentations. The very latest in research and treatment of Morgellons will be presented. An evening reception on Saturday ensures attendees ample opportunity to visit with speakers.

"We're excited to welcome new speakers this year," states Cindy Casey-Holman, RN, Director of the foundation. "Morgellons research from Mt. Allison University in New Brunswick will be presented this year for the very first time!" Conference details including list of speakers, registration and hotel information are available on the foundation's website http://www.thecehf.org

About The Charles E. Holman Morgellons Disease Foundation
The Charles E. Holman Morgellons Disease Foundation, based in ?Austin, TX, is a 501(c) (3) nonprofit organization committed to advocacy and philanthropy in the battle against Morgellons. Director, Cindy Casey-Holman, RN, leads the foundation, named for her husband, Charles E. Holman, a pioneer in the fight against MD.

The CEHMDF is the recognized authority and primary funding source for Morgellons Disease medical-scientific research. To learn more about Morgellons Disease go to http://www.MorgellonsDisease.org

Read the full story at http://www.prweb.com/releases/2018/02/prweb15185022.htm.


Page: 1


Related Keywords:
Related Sites: Digital Producer ,   Presentation Master ,   Oceania ,   DMN Newswire ,   VideoBasedTutorials ,   HTN - Health Technology Net
Related Newsletter: DMN Newsletter ,   CMN Newsletter ,   KNews Newsletter ,   DMNForums ,   Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
Seniors

Drugs
  • Sanofi: Dupixent® (dupilumab) showed positive Phase 3 results in adolescents with inadequately controlled moderate-to-severe atopic dermatitis
  • Global Sleep Apnea Diagnostic and Therapeutic Devices: 2016/18-2024 Strategic Business Analysis & Forecast Report - mHealth-Enabled Sleep Tracking Devices Gain Ground
  • Blavatnik Family Foundation Provides $10 Million Gift to Mount Sinai to Support Mission of Advancing Women’s Health
  • Smart Contact Lenses Market 2018 Upgrading To Foster Growth At a CAGR of 10.4% | By Application; Continuous Glucose Monitoring, Intraocular Pressure Monitoring And Others Till 2023
  • Global Big Data in Healthcare Market: Analysis and Forecast, 2017-2025 (Focus on Components and Services, Applications, Competitive Landscape and Country Analysis)

    Cancer
  • Synovial Sarcoma Treatment Market, by Treatment Type Chemotherapy
  • Multiple New Vendor GPO Awards Position Keneric Healthcare to Increase Its Market Reach for Their Advanced Wound Care and Patient Cleansing Products Lines
  • RXi Pharmaceuticals Announces Positive Results from Phase 2 Trial with Samcyprone™ for the Treatment of Common Warts
  • Avicanna Inc. Proudly Hosts the "International Symposium on Cannabinoids & Medical Applications"
  • Stock-Sector Releases Interview with CEO of Helomics Discussing Precision Medicine with Precision Therapeutics
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines